{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:03:16Z","timestamp":1753891396184,"version":"3.41.2"},"reference-count":141,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p><jats:italic>Burkholderia pseudomallei<\/jats:italic>, the gram-negative bacterium that causes melioidosis, is notoriously difficult to treat with antibiotics. A significant effort has focused on identifying protective vaccine strategies to prevent melioidosis. However, when used as individual medical countermeasures both antibiotic treatments (therapeutics or post-exposure prophylaxes) and experimental vaccine strategies remain partially protective. Here we demonstrate that when used in combination, current vaccine strategies (recombinant protein subunits AhpC and\/or Hcp1 plus capsular polysaccharide conjugated to CRM197 or the live attenuated vaccine strain<jats:italic>B. pseudomallei<\/jats:italic>668 \u0394<jats:italic>ilvI<\/jats:italic>) and co-trimoxazole regimens can result in near uniform protection in a mouse model of melioidosis due to apparent synergy associated with distinct medical countermeasures. Our results demonstrated significant improvement when examining several suboptimal antibiotic regimens (e.g., 7-day antibiotic course started early after infection or 21-day antibiotic course with delayed initiation). Importantly, this combinatorial strategy worked similarly when either protein subunit or live attenuated vaccines were evaluated. Layered and integrated medical countermeasures will provide novel treatment options for melioidosis as well as diseases caused by other pathogens that are refractory to individual strategies, particularly in the case of engineered, emerging, or re-emerging bacterial biothreat agents.<\/jats:p>","DOI":"10.3389\/fmicb.2022.965572","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T08:08:41Z","timestamp":1660723721000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Layered and integrated medical countermeasures against Burkholderia pseudomallei infections in C57BL\/6 mice"],"prefix":"10.3389","volume":"13","author":[{"given":"Christopher P.","family":"Klimko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Shoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathaniel O.","family":"Rill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Dankmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuli","family":"Talyansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey K.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlyn E.","family":"Orne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Fetterer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergei S.","family":"Biryukov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary N.","family":"Burtnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Brett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"DeShazer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher K.","family":"Cote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1017\/S0950268805004103","article-title":"Changing epidemiology of melioidosis? A case of acute pulmonary melioidosis with fatal outcome imported from Brazil.","volume":"133","author":"Aardema","year":"2005","journal-title":"Epidemiol. Infect."},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics8040182","article-title":"Phage-Antibiotic Combination Treatments: Antagonistic impacts of antibiotics on the pharmacodynamics of phage therapy?","volume":"8","author":"Abedon","year":"2019","journal-title":"Antibiotics"},{"key":"B3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2147\/IDR.S166236","article-title":"Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides.","volume":"11","author":"Almaaytah","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines7040196","article-title":"Deletion of two genes in Burkholderia pseudomallei MSHR668 that target essential amino acids protect acutely infected BALB\/c mice and promotelLong term survival.","volume":"7","author":"Amemiya","year":"2019","journal-title":"Vaccines"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094943","article-title":"Strategies to tackle antimicrobial resistance: The example of Escherichia coli and Pseudomonas aeruginosa.","volume":"22","author":"Antonelli","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"5290","DOI":"10.1128\/IAI.70.9.5290-5294.2002","article-title":"A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis.","volume":"70","author":"Atkins","year":"2002","journal-title":"Infect. Immun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e00082","DOI":"10.1128\/AAC.00082-17","article-title":"Demonstrating the protective efficacy of the novel fluoroquinolone finafloxacin against an inhalational exposure to Burkholderia pseudomallei.","volume":"61","author":"Barnes","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B8","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ijantimicag.2013.02.007","article-title":"Trimethoprim\/sulfamethoxazole (co-trimoxazole) prophylaxis is effective against acute murine inhalational melioidosis and glanders.","volume":"41","author":"Barnes","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172627","article-title":"Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB\/c and C57BL\/6 mice.","volume":"12","author":"Bearss","year":"2017","journal-title":"PLoS One"},{"key":"B10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00203-016-1303-8","article-title":"Characterization of in vitro phenotypes of Burkholderia pseudomallei and Burkholderia mallei strains potentially associated with persistent infection in mice.","volume":"199","author":"Bernhards","year":"2017","journal-title":"Arch. Microbiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1128\/AAC.04593-14","article-title":"Efficacy of ETI-204 monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for inhalational anthrax.","volume":"59","author":"Biron","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B12","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.965518","article-title":"Evaluation of two differernt vaccine platforms for immunzation against melioidosis and glanders.","author":"Biryukov","year":"2022","journal-title":"Front. Microbiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1128\/IAI.00451-10","article-title":"Resolution of Staphylococcus aureus biofilm infection using vaccination and antibiotic treatment.","volume":"79","author":"Brady","year":"2011","journal-title":"Infect. Immun."},{"key":"B14","first-page":"223","article-title":"Melioidosis","author":"Brett","year":"2018","journal-title":"Textbook of military medicine: Medical aspects of biological warfare"},{"key":"B15","doi-asserted-by":"publisher","first-page":"945","DOI":"10.2174\/1381612033455189","article-title":"Immune therapy for infectious diseases at the dawn of the 21st century: The past, present and future role of antibody therapy, therapeutic vaccination and biological response modifiers.","volume":"9","author":"Buchwald","year":"2003","journal-title":"Curr. Pharm. Des."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2012.00108","article-title":"Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders.","volume":"2","author":"Burtnick","year":"2012","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e00724","DOI":"10.1128\/IAI.00724-17","article-title":"Development of subunit vaccines that provide high-level protection and sterilizing immunity against acute inhalational melioidosis.","volume":"86","author":"Burtnick","year":"2018","journal-title":"Infect. Immun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nrmicro974","article-title":"Passive antibody therapy for infectious diseases.","volume":"2","author":"Casadevall","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"journal-title":"Centers for Disease Control and Presention NCfEaZIDN, Division of High-Consequence Pathogens and Pathology (DHCPP). 2021 multistate outbreak of melioidosis.","year":"2021","key":"B19"},{"key":"B20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1128\/CMR.18.2.383-416.2005","article-title":"Melioidosis: Epidemiology, pathophysiology, and management.","volume":"18","author":"Cheng","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.micpath.2015.01.006","article-title":"Transcriptome analysis of Burkholderia pseudomallei T6SS identifies Hcp1 as a potential serodiagnostic marker.","volume":"79","author":"Chieng","year":"2015","journal-title":"Microb. Pathog."},{"key":"B22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ajpath.2011.03.031","article-title":"Low-dose exposure of C57BL\/6 mice to Burkholderia pseudomallei mimics chronic human melioidosis.","volume":"179","author":"Conejero","year":"2011","journal-title":"Am. J. Pathol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-09782-4_1","article-title":"Persister cells in biofilm associated infections.","volume":"831","author":"Conlon","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104050","article-title":"Combinations of early generation antibiotics and antimicrobial peptides are effective against a broad spectrum of bacterial biothreat agents.","volume":"142","author":"Cote","year":"2020","journal-title":"Microb. Pathog."},{"key":"B25","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1183\/09031936.03.00006203","article-title":"Melioidosis: An important cause of pneumonia in residents of and travellers returned from endemic regions.","volume":"22","author":"Currie","year":"2003","journal-title":"Eur. Respir. J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.3201\/eid0912.020750","article-title":"Intensity of rainfall and severity of melioidosis, Australia.","volume":"9","author":"Currie","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/S1473-3099(21)00022-0","article-title":"The Darwin prospective melioidosis study: A 30-year prospective, observational investigation.","volume":"21","author":"Currie","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000900","article-title":"The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study.","volume":"4","author":"Currie","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0001-706X(99)00059-5","article-title":"Melioidosis as an emerging global problem.","volume":"74","author":"Dance","year":"2000","journal-title":"Acta Trop."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.3390\/toxins7061854","article-title":"Monoclonal antibody combinations that present synergistic neutralizing activity: A platform for next-generation anti-toxin drugs.","volume":"7","author":"Diamant","year":"2015","journal-title":"Toxins"},{"key":"B31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/cid\/ciu764","article-title":"Contact investigation of melioidosis cases reveals regional endemicity in Puerto Rico.","volume":"60","author":"Doker","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02700","article-title":"Combination of antibodies and antibiotics as a promising strategy against multidrug-resistant pathogens of the respiratory tract.","volume":"9","author":"Domenech","year":"2018","journal-title":"Front. Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"7301","DOI":"10.1016\/j.vaccine.2007.08.021","article-title":"Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.","volume":"25","author":"Eyles","year":"2007","journal-title":"Vaccine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4137\/PMC.S14459","article-title":"Antibiotics and bacterial resistance in the 21st century.","volume":"6","author":"Fair","year":"2014","journal-title":"Perspect. Med. Chem."},{"key":"B35","first-page":"e02230","article-title":"Antibiotic susceptibility of clinical Burkholderia pseudomallei isolates in northeast Thailand during 2015-2018 and the genomic characterization of beta-lactam-resistant isolates.","volume":"65","author":"Fen","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1146\/annurev.micro.112408.134030","article-title":"Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis.","volume":"64","author":"Galyov","year":"2010","journal-title":"Annu. Rev. Microbiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa2116130","article-title":"Multistate outbreak of melioidosis associated with imported aromatherapy spray.","volume":"386","author":"Gee","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"662","DOI":"10.7326\/0003-4819-68-3-662","article-title":"Potential medical problems in personnel returning from Vietnam.","volume":"68","author":"Gilbert","year":"1968","journal-title":"Ann. Intern. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.immuni.2020.01.001","article-title":"Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad Ebolavirus neutralization.","volume":"52","author":"Gilchuk","year":"2020","journal-title":"Immunity"},{"key":"B40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1086\/523578","article-title":"Vaccines: Countering anthrax: Vaccine and immunoglobulins.","volume":"46","author":"Grabenstein","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1001\/jama.1969.03150170023004","article-title":"Public health problems relating to the Vietnam returnee.","volume":"207","author":"Greenberg","year":"1969","journal-title":"JAMA"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1128\/AAC.00953-10","article-title":"Adaptation and antibiotic tolerance of anaerobic Burkholderia pseudomallei.","volume":"55","author":"Hamad","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006496","article-title":"Immunogenic Burkholderia pseudomallei outer membrane proteins as potential candidate vaccine targets.","volume":"4","author":"Hara","year":"2009","journal-title":"PLoS One"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-10-302","article-title":"Incidence, risk factors and clinical epidemiology of melioidosis: A complex socio-ecological emerging infectious disease in the Alor Setar region of Kedah, Malaysia.","volume":"10","author":"Hassan","year":"2010","journal-title":"BMC Infect. Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1128\/IAI.71.4.2234-2238.2003","article-title":"Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis.","volume":"71","author":"Hill","year":"2003","journal-title":"Infect. Immun."},{"key":"B46","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3201\/eid2105.141610","article-title":"Melioidosis in trinidad and tobago.","volume":"21","author":"Hogan","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"B47","first-page":"56","article-title":"Burkholderia pseudomallei traced to water treatment plant in Australia.","volume":"6","author":"Inglis","year":"2000","journal-title":"Emerg. Infect. Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"947","DOI":"10.4269\/ajtmh.2006.75.947","article-title":"Melioidosis in the Americas.","volume":"75","author":"Inglis","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004301","article-title":"Burkholderia pseudomallei: Its detection in soil and seroprevalence in Bangladesh.","volume":"10","author":"Jilani","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e00876","DOI":"10.1128\/IAI.00876-17","article-title":"Vaccine-linked chemotherapy improves benznidazole efficacy for acute chagas disease.","volume":"86","author":"Jones","year":"2018","journal-title":"Infect. Immun."},{"key":"B51","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.jinf.2016.02.015","article-title":"The association of melioidosis with climatic factors in Darwin, Australia: A 23-year time-series analysis.","volume":"72","author":"Kaestli","year":"2016","journal-title":"J. Infect."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106393","article-title":"Combination therapy with antibiotics and anthrax immune globulin intravenous (AIGIV) is potentially more effective than antibiotics alone in rabbit model of inhalational anthrax.","volume":"9","author":"Kammanadiminti","year":"2014","journal-title":"PLoS One"},{"key":"B53","first-page":"e00570","article-title":"Burkholderia pseudomallei \u0394tonB \u0394hcp1 live attenuated vaccine strain elicits full protective immunity against aerosolized melioidosis infection.","volume":"4","author":"Khakhum","year":"","journal-title":"mSphere"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007578","article-title":"Evaluation of Burkholderia mallei \u0394tonB \u0394hcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis.","volume":"13","author":"Khakhum","year":"","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9020113","article-title":"The impact of age and sex on mouse models of melioidosis.","volume":"9","author":"Klimko","year":"2020","journal-title":"Pathogens"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.vaccine.2009.01.094","article-title":"A single-dose combination therapy that both prevents and treats anthrax infection.","volume":"27","author":"Klinman","year":"2009","journal-title":"Vaccine"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1517\/14712590903307347","article-title":"Anthrax prevention and treatment: Utility of therapy combining antibiotic plus vaccine.","volume":"9","author":"Klinman","year":"2009","journal-title":"Expert Opin. Biol. Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"12896","DOI":"10.1073\/pnas.1721095115","article-title":"Impact of existing vaccines in reducing antibiotic resistance: Primary and secondary effects.","volume":"115","author":"Klugman","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B59","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/archinte.1991.00400030135027","article-title":"Melioidosis. Forgotten, but not gone!","volume":"151","author":"Koponen","year":"1991","journal-title":"Arch. Intern. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4269\/ajtmh.17-0633","article-title":"Prostatic abscess due to Burkholderia pseudomallei: Facilitating diagnosis to optimize management.","volume":"98","author":"Kozlowska","year":"2018","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa103","article-title":"Indirect detection of Burkholderia pseudomallei Infection in a US Marine after training in Australia.","volume":"7","author":"Larson","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1006\/mpat.1997.0179","article-title":"BALB\/c and C57BL\/6 mice infected with virulent Burkholderia pseudomallei provide contrasting animal models for the acute and chronic forms of human melioidosis.","volume":"24","author":"Leakey","year":"1998","journal-title":"Microb. Pathog."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1128\/CVI.00240-12","article-title":"Recombinant protective antigen anthrax vaccine improves survival when administered as a postexposure prophylaxis countermeasure with antibiotic in the New Zealand white rabbit model of inhalation anthrax.","volume":"19","author":"Leffel","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftw070","article-title":"The art of persistence-the secrets to Burkholderia chronic infections.","volume":"74","author":"Lewis","year":"2016","journal-title":"Pathog. Dis."},{"key":"B65","first-page":"267","article-title":"Persister cells and the riddle of biofilm survival.","volume":"70","author":"Lewis","year":"2005","journal-title":"Biochemistry"},{"key":"B66","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/978-3-540-75418-3_6","article-title":"Multidrug tolerance of biofilms and persister cells.","volume":"322","author":"Lewis","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-2238-4","article-title":"Childhood vaccines and antibiotic use in low- and middle-income countries.","volume":"581","author":"Lewnard","year":"2020","journal-title":"Nature"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2014.00258","article-title":"The importance of the viable but non-culturable state in human bacterial pathogens.","volume":"5","author":"Li","year":"2014","journal-title":"Front. Microbiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.7150\/ijbs.60551","article-title":"A combination therapy of phages and antibiotics: Two is better than one.","volume":"17","author":"Li","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-021-00777-9","article-title":"Antibody cocktail effective against variants of SARS-CoV-2.","volume":"28","author":"Liang","year":"2021","journal-title":"J. Biomed. Sci."},{"key":"B71","doi-asserted-by":"crossref","DOI":"10.1038\/srep08235","article-title":"Extended loop region of Hcp1 is critical for the assembly and function of type VI secretion system in Burkholderia pseudomallei.","volume":"5","author":"Lim","year":"2015","journal-title":"Sci. Rep."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3201\/eid2106.141480","article-title":"Consensus on the development of vaccines against naturally acquired melioidosis.","volume":"21","author":"Limmathurotsakul","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"B73","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2015.8","article-title":"Predicted global distribution of and burden of melioidosis.","volume":"1","author":"Limmathurotsakul","year":"2016","journal-title":"Nat. Microbiol."},{"key":"B74","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3201\/eid2002.121891","article-title":"Melioidosis caused by Burkholderia pseudomallei in drinking water, Thailand, 2012.","volume":"20","author":"Limmathurotsakul","year":"","journal-title":"Emerg. Infect. Dis."},{"key":"B75","doi-asserted-by":"crossref","first-page":"O854","DOI":"10.1111\/1469-0691.12614","article-title":"Role of Burkholderia pseudomallei biofilm formation and lipopolysaccharide in relapse of melioidosis.","volume":"20","author":"Limmathurotsakul","year":"","journal-title":"Clin. Microbiol. Infect."},{"key":"B76","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1128\/JCM.01297-07","article-title":"Simultaneous infection with more than one strain of Burkholderia pseudomallei is uncommon in human melioidosis.","volume":"45","author":"Limmathurotsakul","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"B77","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00428-16","article-title":"How can vaccines contribute to solving the antimicrobial resistance problem?","volume":"7","author":"Lipsitch","year":"2016","journal-title":"mBio"},{"key":"B78","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1128\/IAI.70.2.504-511.2002","article-title":"Model of differential susceptibility to mucosal Burkholderia pseudomallei infection.","volume":"70","author":"Liu","year":"2002","journal-title":"Infect. Immun."},{"key":"B79","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3201\/eid2101.140042","article-title":"Association of melioidosis incidence with rainfall and humidity, Singapore, 2003-2012.","volume":"21","author":"Liu","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.3201\/eid1510.090246","article-title":"Melioidosis in a tropical city state, Singapore.","volume":"15","author":"Lo","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"B81","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s00203-003-0621-9","article-title":"Compensatory increase in ahpC gene expression and its role in protecting Burkholderia pseudomallei against reactive nitrogen intermediates.","volume":"180","author":"Loprasert","year":"2003","journal-title":"Arch. Microbiol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1378\/chest.68.2.261","article-title":"Melioidosis: Recrudescence associated with bronchogenic carcinoma twenty-six years following initial geographic exposure.","volume":"68","author":"Mays","year":"1975","journal-title":"Chest"},{"key":"B83","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/cid\/cir808","article-title":"Clinical features and epidemiology of melioidosis pneumonia: Results from a 21-year study and review of the literature.","volume":"54","author":"Meumann","year":"2012","journal-title":"Clin. Infect Dis."},{"key":"B84","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41579-020-00506-3","article-title":"The role of vaccines in combatting antimicrobial resistance.","volume":"19","author":"Micoli","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1128\/AAC.04606-14","article-title":"Added benefit of raxibacumab to antibiotic treatment of inhalational anthrax.","volume":"59","author":"Migone","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B86","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/21645515.2020.1767449","article-title":"Staphylococcal vaccine antigens related to biofilm formation.","volume":"17","author":"Mirzaei","year":"","journal-title":"Hum. Vaccin. Immunother."},{"key":"B87","first-page":"1","article-title":"PIA and rSesC mixture arisen antibodies could inhibit the biofilm-formation in Staphylococcus aureus.","volume":"10","author":"Mirzaei","year":"","journal-title":"Rep. Biochem. Mol. Biol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1128\/AAC.43.3.465","article-title":"Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei.","volume":"43","author":"Moore","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"B89","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.juro.2009.04.010","article-title":"Prostatic abscess due to Burkholderia pseudomallei: 81 cases from a 19-year prospective melioidosis study.","volume":"182","author":"Morse","year":"2009","journal-title":"J. Urol."},{"journal-title":"Guide for the care and use of laboratory animals","year":"2011","key":"B90"},{"key":"B91","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1128\/JCM.43.2.970-972.2005","article-title":"Cutaneous melioidosis in a man who was taken as a prisoner of war by the Japanese during World War II.","volume":"43","author":"Ngauy","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.01338","article-title":"The in vitro antibiotic tolerant persister population in Burkholderia pseudomallei is altered by environmental factors.","volume":"6","author":"Nierman","year":"2015","journal-title":"Front. Microbiol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"8381","DOI":"10.1016\/j.vaccine.2011.08.058","article-title":"A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection.","volume":"29","author":"Nieves","year":"2011","journal-title":"Vaccine"},{"key":"B94","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1128\/CVI.00119-14","article-title":"A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis.","volume":"21","author":"Nieves","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1001\/jama.1967.03120190073010","article-title":"Acute melioidosis in a soldier home from South Vietnam.","volume":"200","author":"Patterson","year":"1967","journal-title":"JAMA"},{"key":"B96","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/01.qco.0000244046.31135.b3","article-title":"Melioidosis.","volume":"19","author":"Peacock","year":"2006","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B97","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.provac.2014.07.007","article-title":"Evaluation of a Burkholderia pseudomallei outer membrane vesicle vaccine in nonhuman primates.","volume":"8","author":"Petersen","year":"2014","journal-title":"Procedia Vaccinol."},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003586","article-title":"Intravenous therapy duration and outcomes in melioidosis: A new treatment paradigm.","volume":"9","author":"Pitman","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B99","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1128\/JCM.01974-06","article-title":"Recurrent melioidosis: Possible role of infection with multiple strains of Burkholderia pseudomallei.","volume":"45","author":"Pitt","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.trstmh.2011.06.004","article-title":"Survival of Burkholderia pseudomallei in distilled water for 16 years.","volume":"105","author":"Pumpuang","year":"2011","journal-title":"Trans. R. Soc. Trop. Med. Hyg"},{"key":"B101","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40121-015-0098-2","article-title":"Burkholderia pseudomallei causing bone and joint infections: A clinical update.","volume":"5","author":"Raja","year":"2016","journal-title":"Infect. Dis. Ther."},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1093\/immadv\/ltaa007","article-title":"Recent advances in immunotherapies against infectious diseases.","volume":"1","author":"Ramamurthy","year":"2021","journal-title":"Immunother. Adv."},{"key":"B103","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1086\/526535","article-title":"The Maxwell Finland Lecture: For the duration-rational antibiotic administration in an era of antimicrobial resistance and Clostridium difficile.","volume":"46","author":"Rice","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246156","article-title":"Impact of influenza vaccination on amoxicillin prescriptions in older adults: A retrospective cohort study using primary care data.","volume":"16","author":"Rodgers","year":"2021","journal-title":"PLoS One"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1093\/jac\/dkv023","article-title":"Synergy of chemotherapy and immunotherapy revealed by a genome-scale analysis of murine tuberculosis.","volume":"70","author":"Rodrigues","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"B106","doi-asserted-by":"publisher","first-page":"e000654","DOI":"10.1128\/IAI.00654-20","article-title":"Burkholderia pseudomallei as an enteric pathogen: Identification of virulence factors mediating gastrointestinal infection.","volume":"89","author":"Sanchez-Villamil","year":"2020","journal-title":"Infect Immun."},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030789","article-title":"Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia.","volume":"7","author":"Sarovich","year":"2012","journal-title":"PLoS One"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009196","article-title":"Growing Burkholderia pseudomallei in biofilm stimulating conditions significantly induces antimicrobial resistance.","volume":"5","author":"Sawasdidoln","year":"2010","journal-title":"PLoS One"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00222-22","article-title":"Development of melioidosis subunit vaccines using an enzymatically inactive Burkholderia pseudomallei AhpC.","author":"Schmidt","year":"2022","journal-title":"Infect Immun."},{"key":"B110","first-page":"8","article-title":"Serological evidence of Burkholderia pseudomallei infection in U.S. Marines who trained in Australia from 2012-2014: A retrospective analysis of archived samples.","volume":"26","author":"Schully","year":"2019","journal-title":"MSMR"},{"key":"B111","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1128\/IAI.01847-14","article-title":"Burkholderia pseudomallei capsular polysaccharide conjugates provide protection against acute melioidosis.","volume":"82","author":"Scott","year":"2014","journal-title":"Infect. Immun."},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.698303","article-title":"Melioidosis patient survival correlates with strong IFN-\u03b3 secreting T Cell responses against Hcp1 and TssM","volume":"12","author":"Sengyee","year":"2021","journal-title":"Front. Immunol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"4626","DOI":"10.1128\/IAI.00915-13","article-title":"Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine.","volume":"81","author":"Silva","year":"2013","journal-title":"Infect Immun."},{"key":"B114","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/jac\/dkm527","article-title":"Pre- and post-exposure prophylaxis of experimental Burkholderia pseudomallei infection with doxycycline, amoxicillin\/clavulanic acid and co-trimoxazole.","volume":"61","author":"Sivalingam","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"B115","first-page":"251","article-title":"Disseminated melioidosis with spinal intraosseous abscess.","volume":"76","author":"Soo","year":"2021","journal-title":"Med. J. Malaysia"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1086\/516362","article-title":"Combination immunotherapy and antifungal chemotherapy.","volume":"26","author":"Stevens","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008659","article-title":"2020 Review and revision of the 2015 Darwin melioidosis treatment guideline; paradigm drift not shift.","volume":"14","author":"Sullivan","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B118","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ijid.2019.01.019","article-title":"Oral eradication therapy for melioidosis: Important but not without risks.","volume":"80","author":"Sullivan","year":"2019","journal-title":"Int. J. Infect. Dis."},{"key":"B119","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1089\/mdr.1998.4.289","article-title":"Antibiotic resistance in Escherichia coli of the normal intestinal flora of swine.","volume":"4","author":"Sunde","year":"1998","journal-title":"Microb. Drug Resist."},{"key":"B120","first-page":"649","article-title":"Rheumatological manifestations in patients with melioidosis.","volume":"39","author":"Teparrakkul","year":"2008","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"B121","doi-asserted-by":"publisher","first-page":"5981","DOI":"10.1016\/j.vaccine.2017.03.022","article-title":"Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials?","volume":"35","author":"Titball","year":"2017","journal-title":"Vaccine"},{"key":"B122","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1016\/S0035-9203(08)70026-9","article-title":"Burkholderia pseudomallei: Animal models of infection.","volume":"102","author":"Titball","year":"2008","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208277","article-title":"Disease progression in mice exposed to low-doses of aerosolized clinical isolates of Burkholderia pseudomallei.","volume":"13","author":"Trevino","year":"2018","journal-title":"PLoS One"},{"key":"B124","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/jac\/dkg011","article-title":"A comparison of antibiotic regimens in the treatment of acute melioidosis in a mouse model.","volume":"51","author":"Ulett","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"B125","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1469-0691.1998.tb00038.x","article-title":"High rates of antibiotic resistance among normal fecal flora Escherichia coli isolates in children from Greece.","volume":"4","author":"Vatopoulos","year":"1998","journal-title":"Clin. Microbiol. Infect."},{"key":"B126","doi-asserted-by":"publisher","first-page":"e1011","DOI":"10.1093\/cid\/ciab062","article-title":"Leveraging vaccines to reduce antibiotic use and prevent antimicrobial resistance: A World Health Organization action framework.","volume":"73","author":"Vekemans","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"B127","first-page":"277","article-title":"The antibiotic resistance crisis: Part 1: Causes and threats.","volume":"40","author":"Ventola","year":"","journal-title":"P T."},{"key":"B128","first-page":"344","article-title":"The antibiotic resistance crisis: Part 2: Management strategies and new agents.","volume":"40","author":"Ventola","year":"","journal-title":"P T."},{"key":"B129","doi-asserted-by":"publisher","first-page":"7813","DOI":"10.1073\/pnas.0602748103","article-title":"Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax.","volume":"103","author":"Vietri","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B130","first-page":"379","article-title":"Electron microscopy study of the mode of growth of Pseudomonas pseudomallei in vitro and in vivo.","volume":"98","author":"Vorachit","year":"1995","journal-title":"J. Trop. Med. Hyg."},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.674068","article-title":"Combination therapy of phage vB_KpnM_P-KP2 and gentamicin combats acute pneumonia caused by K47 serotype Klebsiella pneumoniae.","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Microbiol."},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2015.07.004","article-title":"Characterization of Burkholderia pseudomallei strains using a murine intraperitoneal infection model and in vitro macrophage assays.","volume":"10","author":"Welkos","year":"2015","journal-title":"PLoS One"},{"key":"B133","first-page":"227","article-title":"Management of war wounds.","volume":"3","author":"Whelan","year":"1968","journal-title":"Adv. Surg."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1056\/NEJMra1204699","article-title":"Melioidosis.","volume":"367","author":"Wiersinga","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"B135","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrmicro1385","article-title":"Melioidosis: Insights into the pathogenicity of Burkholderia pseudomallei.","volume":"4","author":"Wiersinga","year":"2006","journal-title":"Nat. Rev. Microbiol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1128\/CDLI.6.6.832-837.1999","article-title":"Antibiotics modulate vaccine-induced humoral immune response.","volume":"6","author":"Woo","year":"1999","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.654745","article-title":"Osteomyelitis and septic arthritis due to Burkholderia pseudomallei: A 10-Year retrospective melioidosis study from south China.","volume":"11","author":"Wu","year":"2021","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1093\/jac\/dki151","article-title":"Trimethoprim\/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei.","volume":"55","author":"Wuthiekanun","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"B139","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3201\/eid2002.131314","article-title":"Burkholderia pseudomallei isolates in 2 pet iguanas, California, USA.","volume":"20","author":"Zehnder","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01483","article-title":"Molecular mechanisms of AhpC in resistance to oxidative stress in Burkholderia thailandensis.","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Microbiol."},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00128","article-title":"Application of antimicrobial peptides of the innate immune system in combination with conventional antibiotics-A novel way to combat antibiotic resistance?","volume":"9","author":"Zharkova","year":"2019","journal-title":"Front. Cell Infect. Microbiol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.965572\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T01:31:20Z","timestamp":1676424680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.965572\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,17]]},"references-count":141,"alternative-id":["10.3389\/fmicb.2022.965572"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2022.965572","relation":{},"ISSN":["1664-302X"],"issn-type":[{"type":"electronic","value":"1664-302X"}],"subject":[],"published":{"date-parts":[[2022,8,17]]},"article-number":"965572"}}